Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00441194
Other study ID # HSOCT001
Secondary ID
Status Terminated
Phase Phase 4
First received February 27, 2007
Last updated March 2, 2012
Start date November 2006
Est. completion date May 2007

Study information

Verified date March 2012
Source Haag Streit USA
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

To compare the Octopus 311 and the HFA 700 series


Description:

To compare the Octopus 311 and the HFA 700 series to evaluate reliability, reproducibility, test duration, patient preference and technician preference.


Recruitment information / eligibility

Status Terminated
Enrollment 80
Est. completion date May 2007
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Prior Visual Field

Exclusion Criteria:

- Scotopic pupil less than 3 mm

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
Visual Field (Octopus 311 and the HFA 700 series)


Locations

Country Name City State
United States Capital Eye Consultants Fairfax Virginia

Sponsors (1)

Lead Sponsor Collaborator
Haag Streit USA

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06054763 - Buyang Huanwu Decoction and Normal Tension Glaucoma N/A
Completed NCT01021982 - Evaluation of Objective Perimetry Using Pupillometer N/A
Completed NCT00727168 - Screening for Glaucoma in Namil Area, South Korea N/A
Completed NCT01051739 - Variability in Perimetry Study N/A
Completed NCT05739487 - Changes of Visual Field Defects After IAT for CRAO
Recruiting NCT04499157 - Effect of MEMOPTIC on Visual Field of Patients Followed for a Chronic Open-angle Glaucoma N/A